50 results
Page 2 of 3
8-K
EX-99.1
b6g5b3uqdg
24 Mar 22
Yumanity Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Developments
4:21pm
8-K
EX-99.1
h4wrf1 r2z
17 Feb 22
Yumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces Restructuring
8:37am
8-K
c22b5phidtzk
17 Feb 22
Yumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces Restructuring
8:37am
8-K/A
EX-99.1
3042n r07
8 Apr 21
Financial Statements and Exhibits
8:42am
8-K/A
EX-99.6
y0euys814a0o q9i
3 Feb 21
Other Events
4:59pm
8-K
EX-99.2
bmgj7o9r0wip maya0
4 Dec 20
Other Events
5:17pm
425
EX-99.2
1sxai34q1jiq
4 Dec 20
Business combination disclosure
5:16pm
424B3
byho levhof9kdjd
12 Nov 20
Prospectus supplement
6:08am
S-4/A
027ez unqvm1e8h
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm
CORRESP
3jlrxpyhr
28 Oct 20
Correspondence with SEC
12:00am
S-4
vdzvu
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
8-K
4ss4y9v8kx9k78v1
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
8-K
EX-99.3
3v0yvejsdmu0bb
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
8-K
EX-99.1
0rh75m jewzq5x3by3z2
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
425
EX-99.3
gdltctmcri 3d
24 Aug 20
Business combination disclosure
5:28pm